Oct 31, 2024
Accenture and 1910 Genetics Partner to Accelerate AI-Driven Drug Discovery. (Source)
Servier and Aitia Partner to Advance Glioma Drug Discovery with AI and Digital Twins. (Source)
Oct 30, 2024
Archon Biosciences debuts with $20M seed funding to pioneer “antibody cages,” a novel class of therapeutics. (Source)
Insilico Medicine and Sanofi’s AI-driven drug discovery partnership reaches a significant milestone. (Source)
Oct 21, 2024
Recursion and Google Cloud collaborate on generative AI for drug discovery. (Source)
Oct 16, 2024
Exscientia‘s collaboration with Sanofi yields significant milestones, showcasing its ability to create innovative drug candidates. The company receives $15 million and is eligible for substantial future payments and royalties. Small molecule, drug discovery, AI (Source)
Mila and Ability Biologics collaborate on AI-driven antibody discovery. (Source)
Oct 15, 2024
Antiverse secures $4.6 million to develop AI-powered antibody platform. (Source)
Oct 10, 2024
XtalPi, a global leader in AI drug discovery, announced a licensing agreement for its proprietary biologics AI platform between its division, Ailux Biologics, and Janssen Biotech, a Johnson & Johnson company. (Source)
Eurofins Discovery renewed its partnership with Dompé farmaceutici to accelerate drug discovery using AI. (Source)
Oct 09, 2024
Exscientia to Unveil Promising Preclinical Data on AI-Designed LSD1 and MALT1 Inhibitors at ENA 2024. (Source)
Basecamp Research raises $60M for AI-powered drug discovery and programmable genetic medicines. (Source)
Insitro, a leader in AI-driven drug discovery, has partnered with Eli Lilly to accelerate the development of novel treatments for metabolic diseases. The companies will collaborate on potential new medicines targeting metabolic dysfunction-associated steatotic liver disease (MASLD), identified through Insitro’s advanced machine learning platform. (Source)
Oct 08, 2024
Tonix Pharmaceuticals partners with X‑Chem to leverage AI and ML for developing orally available, broad-spectrum antivirals. (Source)
Oct 02, 2024
AWS, Deloitte, Microsoft, and NVIDIA partner with the Cancer AI Alliance (CAIA), providing initial funding, AI expertise, and collaborative efforts. (Source) Four National Cancer Institute-designated cancer centers – Dana-Farber Cancer Institute, Fred Hutch Cancer Center, Memorial Sloan Kettering Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins have joined forces to form the Cancer AI Alliance (CAIA).
Charles River and Lundbeck team up to accelerate neurological drug discovery using Logica®, an AI-powered platform. (Source)
Oct 01, 2024
BioNTech and their AI-powered subsidiary, InstaDeep, reveal their latest AI developments. Immunotherapy, drug discovery & development, AI (Source)
